SCOPUS 정보 검색 플랫폼

Volumn 50, Issue 10, 2009, Pages 1229-1248

Chronic inflammatory intestinal diseases: Pathophysiology and therapy;Chronisch entzündliche darmerkrankungen: Pathophysiologie und therapie

(3) Herrlinger, K a Wittig, B b Stange, E F a

a ROBERT BOSCH HOSPITAL (Germany)

b ABBOTT GMBH AND CO KG (Germany)

Author keywords

Colitis ulcerosa; Crohn's disease; Defensins; Immunosuppression; Innate immunity

Indexed keywords

CHRONIC DISEASE; ENTERITIS; EVIDENCE BASED PRACTICE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

CHRONIC DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MODELS, BIOLOGICAL;

EID: 70350303339 PISSN: 00209554 EISSN: None Source Type: Journal
DOI: 10.1007/s00108-009-2485-9 Document Type: Review

Times cited : (4)

References (38)

1
- 77950150465
- 14974022
- Akobeng 2004 Cochrane Database Syst Rev 1 CD003574 14974022
- (2004) Cochrane Database Syst Rev , vol.1 , pp. 003574
- Akobeng¹

2
- 58149265605
- 10.3748/wjg.14.5154 1:CAS:528:DC%2BD1MXmtVClsw%3D%3D 18777592
- Andoh 2008 World J Gastroenterol 14 5154 10.3748/wjg.14.5154 1:CAS:528:DC%2BD1MXmtVClsw%3D%3D 18777592
- (2008) World J Gastroenterol , vol.14 , pp. 5154
- Andoh¹

3
- 70350329474
- Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis
- [Epub ahead of print]
- Braun A, Treede I, Gotthardt D et al. (2009) Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis. Inflamm Bowel Dis [Epub ahead of print]
- (2009) Inflamm Bowel Dis
- Braun, A.¹ Treede, I.² Gotthardt, D.³

4
- 0024803939
- A meta-analysis of the role of smoking in inflammatory bowel disease
- DOI 10.1007/BF01536701
- Calkins 1989 Dig Dis Sci 34 1841 10.1007/BF01536701 1:STN:280: DyaK3c%2FptFOjtA%3D%3D 2598752 (Pubitemid 20018648)
- (1989) Digestive Diseases and Sciences , vol.34 , Issue.12 , pp. 1841-1854
- Calkins, B.M.¹

5
- 0030775667
- Mesalamine in the maintenance treatment of Crohn's disease: A meta- analysis adjusted for confounding variables
- DOI 10.1053/gast.1997.v113.pm9352848
- Cammà 1997 Gastroenterology 113 1465 10.1053/gast.1997.v113. pm9352848 9352848 (Pubitemid 27461232)
- (1997) Gastroenterology , vol.113 , Issue.5 , pp. 1465-1473
- Camma, C.¹ Giunta, M.² Rosselli, M.³ Cottone, M.⁴

6
- 1642492954
- Antibiotic use and the development of Crohn's disease
- DOI 10.1136/gut.2003.025239
- Card 2004 Gut 53 246 10.1136/gut.2003.025239 1:STN:280: DC%2BD2c%2FlsVyisQ%3D%3D 14724158 (Pubitemid 38125513)
- (2004) Gut , vol.53 , Issue.2 , pp. 246-250
- Card, T.¹ Logan, R.F.A.² Rodrigues, L.C.³ Wheeler, J.G.⁴

7
- 40049084811
- Inflammatory bowel disease: Genetic and epidemiologic considerations
- DOI 10.3748/wjg.14.338
- Cho 2008 World J Gastroenterol 14 338 10.3748/wjg.14.338 1:CAS:528:DC%2BD1cXjvFKkt78%3D 18200657 (Pubitemid 351320843)
- (2008) World Journal of Gastroenterology , vol.14 , Issue.3 , pp. 338-347
- Cho, J.H.¹

8
- 39449085441
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- DOI 10.1016/S0140-6736(08)60304-9, PII S0140673608603049
- D 2008 Lancet 371 660 10.1016/S0140-6736(08)60304-9 (Pubitemid 351284485)
- (2008) The Lancet , vol.371 , Issue.9613 , pp. 660-667
- D'Haens, G.¹ Baert, F.² Van Assche, G.³ Caenepeel, P.⁴ Vergauwe, P.⁵ Tuynman, H.⁶ De Vos, M.⁷ Van Deventer, S.⁸ Stitt, L.⁹ Donner, A.¹⁰ Vermeire, S.¹¹ Van De Mierop, F.J.¹² Coche, J.-C.R.¹³ Van Der Woude, J.¹⁴ Ochsenkuhn, T.¹⁵ Van Bodegraven, A.A.¹⁶ Van Hootegem, P.P.¹⁷ Lambrecht, G.L.¹⁸ Mana, F.¹⁹ Rutgeerts, P.²⁰ Feagan, B.G.²¹ Hommes, D.²² more..

9
- 53249097726
- 10.1053/j.gastro.2008.07.010
- D 2008 Gastroenterology 135 1123 10.1053/j.gastro.2008.07.010
- (2008) Gastroenterology , vol.135 , pp. 1123

10
- 33748558056
- A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon
- DOI 10.1086/505915
- Fellermann 2006 Am J Hum Genet 79 439 10.1086/505915 1:CAS:528: DC%2BD28Xpt1Sntrs%3D 16909382 (Pubitemid 44384253)
- (2006) American Journal of Human Genetics , vol.79 , Issue.3 , pp. 439-448
- Fellermann, K.¹ Stange, D.E.² Schaeffeler, E.³ Schmalzl, H.⁴ Wehkamp, J.⁵ Bevins, C.L.⁶ Reinisch, W.⁷ Teml, A.⁸ Schwab, M.⁹ Lichter, P.¹⁰ Radlwimmer, B.¹¹ Stange, E.F.¹²

11
- 60549086579
- 10.1016/j.diff.2008.09.008 1:CAS:528:DC%2BD1MXit1Ck 19281767
- Gersemann 2009 Differentiation 77 84 10.1016/j.diff.2008.09.008 1:CAS:528:DC%2BD1MXit1Ck 19281767
- (2009) Differentiation , vol.77 , pp. 84
- Gersemann¹

12
- 54049150042
- 10.1055/s-2008-1027796 1:STN:280:DC%2BD1cnotVGgsw%3D%3D 18810679
- Hoffmann 2008 Z Gastroenterol 46 1094 10.1055/s-2008-1027796 1:STN:280:DC%2BD1cnotVGgsw%3D%3D 18810679
- (2008) Z Gastroenterol , vol.46 , pp. 1094
- Hoffmann¹

13
- 7044243293
- Diagnostik und therapie der colitis ulcerosa: Ergebnisse einer evidenzbasierten konsensuskonferenz der Deutschen gesellschaft fur verdauungs- und stoffwechselerkrankungen zusammen mit dem kompetenznetz chronisch entzundliche darmerkrankungen
- DOI 10.1055/s-2004-813510
- Hoffmann 2004 Z Gastroenterol 42 979 10.1055/s-2004-813510 1:STN:280:DC%2BD2cvos1yqsA%3D%3D 15455267 (Pubitemid 39625605)
- (2004) Zeitschrift fur Gastroenterologie , vol.42 , Issue.9 , pp. 979-983
- Hoffmann, J.C.¹ Zeitz, M.² Bischoff, S.C.³ Brambs, H.J.⁴ Bruch, H.P.⁵ Buhr, H.J.⁶ Dignass, A.⁷ Fischer, I.⁸ Fleig, W.⁹ Folsch, U.R.¹⁰ Herrlinger, K.¹¹ Hohne, W.¹² Jantschek, G.¹³ Kaltz, B.¹⁴ Keller, K.M.¹⁵ Knebel, U.¹⁶ Kroesen, A.J.¹⁷ Kruis, W.¹⁸ Matthes, H.¹⁹ Moser, G.²⁰ more..

14
- 2942706073
- Differential TNF-signaling in chronic inflammatory disorders
- DOI 10.2174/1566524043360636
- Holtmann 2004 Curr Mol Med 4 439 10.2174/1566524043360636 1:CAS:528:DC%2BD2cXksFGjt7g%3D 15354874 (Pubitemid 38787012)
- (2004) Current Molecular Medicine , vol.4 , Issue.4 , pp. 439-444
- Holtmann, M.H.¹ Neurath, M.F.²

15
- 84887212530
- 10.1371/journal.pone.0004496 19221600
- Koslowski 2009 PLoS ONE 4 e4496 10.1371/journal.pone.0004496 19221600
- (2009) PLoS ONE , vol.4 , pp. 4496
- Koslowski¹

16
- 0033989184
- 10.1111/j.1572-0241.2000.01680.x 1:STN:280:DC%2BD3c7gt1WitA%3D%3D 10638578
- Koutroubakis 2000 Am J Gastroenterol 95 171 10.1111/j.1572-0241.2000. 01680.x 1:STN:280:DC%2BD3c7gt1WitA%3D%3D 10638578
- (2000) Am J Gastroenterol , vol.95 , pp. 171
- Koutroubakis¹

17
- 58849136710
- 10.1136/gut.2008.154302 1:CAS:528:DC%2BD1MXisFSgsrw%3D 18832520
- Kruis 2009 Gut 58 233 10.1136/gut.2008.154302 1:CAS:528: DC%2BD1MXisFSgsrw%3D 18832520
- (2009) Gut , vol.58 , pp. 233
- Kruis¹

18
- 20444483170
- A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
- DOI 10.1053/j.gastro.2005.03.031, PII S0016508505004488
- Lemann 2005 Gastroenterology 128 1812 10.1053/j.gastro.2005.03.031 1:CAS:528:DC%2BD2MXlvFKls7k%3D 15940616 (Pubitemid 40824692)
- (2005) Gastroenterology , vol.128 , Issue.7 , pp. 1812-1818
- Lemann, M.¹ Mary, J.-Y.² Colombel, J.-F.³ Duclos, B.⁴ Soule, J.-C.⁵ Lerebours, E.⁶ Modigliani, R.⁷ Bouhnik, Y.⁸

19
- 0029044783
- 1:STN:280:DyaK2MzotlGhsA%3D%3D 7654892
- Marshall 1995 Aliment Pharmacol Ther 9 293 1:STN:280:DyaK2MzotlGhsA%3D%3D 7654892
- (1995) Aliment Pharmacol Ther , vol.9 , pp. 293
- Marshall¹

20
- 21044433011
- Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: A randomised, double blind, placebo controlled study
- DOI 10.1136/gut.2004.060103
- Marteau 2005 Gut 54 960 10.1136/gut.2004.060103 1:CAS:528: DC%2BD2MXmsFKqsbc%3D 15951542 (Pubitemid 40873909)
- (2005) Gut , vol.54 , Issue.7 , pp. 960-965
- Marteau, P.¹ Probert, C.S.² Lindgren, S.³ Gassul, M.⁴ Tan, T.G.⁵ Dignass, A.⁶ Befrits, R.⁷ Midhagen, G.⁸ Rademaker, J.⁹ Foldager, M.¹⁰

21
- 34548130847
- Reduced mucosal antimicrobial activity in Crohn's disease of the colon
- DOI 10.1136/gut.2006.118646
- Nuding 2007 Gut 56 1240 10.1136/gut.2006.118646 17456510 (Pubitemid 47300425)
- (2007) Gut , vol.56 , Issue.9 , pp. 1240-1247
- Nuding, S.¹ Fellermann, K.² Wehkamp, J.³ Stange, E.F.⁴

22
- 33747790601
- A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
- DOI 10.1136/gut.2005.081794
- Ogata 2006 Gut 55 1255 10.1136/gut.2005.081794 1:CAS:528: DC%2BD28XhtVehurnE 16484504 (Pubitemid 44277355)
- (2006) Gut , vol.55 , Issue.9 , pp. 1255-1262
- Ogata, H.¹ Matsui, T.² Nakamura, M.³ Iida, M.⁴ Takazoe, M.⁵ Suzuki, Y.⁶ Hibi, T.⁷

23
- 67650416300
- 19160175
- Prefontaine 2009 Cochrane Database Syst Rev 1 CD000067 19160175
- (2009) Cochrane Database Syst Rev , vol.1 , pp. 000067
- Prefontaine¹

24
- 28844473957
- Infliximab for induction and maintenance therapy for ulcerative colitis
- DOI 10.1056/NEJMoa050516
- Rutgeerts 2005 N Engl J Med 353 2462 10.1056/NEJMoa050516 1:CAS:528:DC%2BD2MXhtlShurjE 16339095 (Pubitemid 41770166)
- (2005) New England Journal of Medicine , vol.353 , Issue.23 , pp. 2462-2476
- Rutgeerts, P.¹ Sandborn, W.J.² Feagan, B.G.³ Reinisch, W.⁴ Olson, A.⁵ Johanns, J.⁶ Travers, S.⁷ Rachmilewitz, D.⁸ Hanauer, S.B.⁹ Lichtenstein, G.R.¹⁰ De Villiers, W.J.S.¹¹ Present, D.¹² Sands, B.E.¹³ Colombel, J.F.¹⁴

25
- 84921430591
- 10796557
- Sandborn 2000 Cochrane Database Syst Rev 2 CD000545 10796557
- (2000) Cochrane Database Syst Rev , vol.2 , pp. 000545
- Sandborn¹

26
- 70350329292
- Sandborn 2009 Gastroenterology 136 A
- (2009) Gastroenterology , vol.136
- Sandborn¹

27
- 38649115342
- Microbial Influences in Inflammatory Bowel Diseases
- DOI 10.1053/j.gastro.2007.11.059, PII S0016508507021579
- Sartor 2008 Gastroenterology 134 577 10.1053/j.gastro.2007.11.059 1:CAS:528:DC%2BD1cXivFOjs7o%3D 18242222 (Pubitemid 351173057)
- (2008) Gastroenterology , vol.134 , Issue.2 , pp. 577-594
- Sartor, R.B.¹

28
- 0012912926
- UNI-MED, Bremen
- Stange EF (2009) Colitis ulcerosa - Morbus Crohn. UNI-MED, Bremen
- (2009) Colitis Ulcerosa - Morbus Crohn
- Stange, E.F.¹

29
- 21044457089
- Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
- DOI 10.1136/gut.2004.052316
- Stremmel 2005 Gut 54 966 10.1136/gut.2004.052316 1:CAS:528: DC%2BD2MXmsFKqtr4%3D 15951544 (Pubitemid 40873911)
- (2005) Gut , vol.54 , Issue.7 , pp. 966-971
- Stremmel, W.¹ Merle, U.² Zahn, A.³ Autschbach, F.⁴ Hinz, U.⁵ Ehehalt, R.⁶

30
- 58749105841
- 1:CAS:528:DC%2BD1cXht1KrtrrP 18941183
- Stritesky 2008 J Immunol 181 5948 1:CAS:528:DC%2BD1cXht1KrtrrP 18941183
- (2008) J Immunol , vol.181 , pp. 5948
- Stritesky¹

31
- 84921430451
- Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
- Sutherland L, Roth D, Beck P et al. (2002) Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev CD000544
- (2002) Cochrane Database Syst Rev CD000544
- Sutherland, L.¹ Roth, D.² Beck, P.³

32
- 33745042439
- 16625536
- Sutherland 2006 Cochrane Database Syst Rev 2 CD000543 16625536
- (2006) Cochrane Database Syst Rev , vol.2 , pp. 000543
- Sutherland¹

33
- 0036140777
- 10.1053/gast.2002.30294 11781279
- Swidsinski 2002 Gastroenterology 122 44 10.1053/gast.2002.30294 11781279
- (2002) Gastroenterology , vol.122 , pp. 44
- Swidsinski¹

34
- 33144459948
- European evidence based consensus on the diagnosis and management of Crohn's disease: Current management
- DOI 10.1136/gut.2005.081950b
- Travis 2006 Gut 55 i16 10.1136/gut.2005.081950b 16481629 (Pubitemid 43268291)
- (2006) Gut , vol.55 , Issue.SUPPL. 1
- Travis, S.P.L.¹ Stange, E.F.² Lemann, M.³ Oresland, T.⁴ Chowers, Y.⁵ Forbes, A.⁶ D'Haens, G.⁷ Kitis, G.⁸ Cortot, A.⁹ Prantera, C.¹⁰ Marteau, P.¹¹ Colombel, J.-F.¹² Gionchetti, P.¹³ Bouhnik, Y.¹⁴ Tiret, E.¹⁵ Kroesen, J.¹⁶ Starlinger, M.¹⁷ Mortensen, N.J.McM.¹⁸

35
- 38749095183
- European evidence-based Consensus on the management of ulcerative colitis: Current management
- DOI 10.1016/j.crohns.2007.11.002, PII S1873994607000761
- Travis 2008 J Crohns Colitis 2 24 10.1016/j.crohns.2007.11.002 (Pubitemid 351179488)
- (2008) Journal of Crohn's and Colitis , vol.2 , Issue.1 , pp. 24-62
- Travis, S.P.L.¹ Stange, E.F.² Lemann, M.³ Oresland, T.⁴ Bemelman, W.A.⁵ Chowers, Y.⁶ Colombel, J.F.⁷ D'Haens, G.⁸ Ghosh, S.⁹ Marteau, P.¹⁰ Kruis, W.¹¹ Mortensen, N.J.McC.¹² Penninckx, F.¹³ Gassull, M.¹⁴

36
- 7244257312
- NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
- DOI 10.1136/gut.2003.032805
- Wehkamp 2004 Gut 53 1658 10.1136/gut.2003.032805 1:CAS:528: DC%2BD2cXhtVajtrvK 15479689 (Pubitemid 39434112)
- (2004) Gut , vol.53 , Issue.11 , pp. 1658-1664
- Wehkamp, J.¹ Harder, J.² Weichenthal, M.³ Schwab, M.⁴ Schaffeler, E.⁵ Schlee, M.⁶ Herrlinger, K.R.⁷ Stallmach, A.⁸ Noack, F.⁹ Fritz, P.¹⁰ Schroder, J.M.¹¹ Bevins, C.L.¹² Fellermann, K.¹³ Stange, E.F.¹⁴

37
- 16844382886
- Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease
- DOI 10.1189/jlb.0904543
- Wehkamp 2005 J Leukoc Biol 77 460 10.1189/jlb.0904543 1:CAS:528:DC%2BD2MXjtFajsL0%3D 15618294 (Pubitemid 40489521)
- (2005) Journal of Leukocyte Biology , vol.77 , Issue.4 , pp. 460-465
- Wehkamp, J.¹ Schmid, M.² Fellermann, K.³ Stange, E.F.⁴

38
- 34249945094
- Defensins and other antimicrobial peptides in inflammatory bowel disease
- DOI 10.1097/MOG.0b013e328136c580, PII 0000157420070700000004
- Wehkamp 2007 Curr Opin Gastroenterol 23 370 10.1097/MOG.0b013e328136c580 1:CAS:528:DC%2BD2sXlvFGkurg%3D 17545771 (Pubitemid 46878947)
- (2007) Current Opinion in Gastroenterology , vol.23 , Issue.4 , pp. 370-378
- Wehkamp, J.¹ Schmid, M.² Stange, E.F.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.